BioSpace News Archive

Athersys, Inc. (Nasdaq: ATHX) today announced that its equity purchase agreement with Aspire Capital Fund LLC (Aspire Capital) has been terminated.

Seagen Inc. (Nasdaq: SGEN) today announced that it will report its second quarter 2022 financial results on Thursday, July 28, 2022 after the close of U.S. financial markets.

today announced that the Company’s recombinant adeno-associated virus (rAAV) vector-based investigational gene therapy for Canavan disease (CD) has shown encouraging early efficacy data and a favorable safety profile in the first three patients treated through their six month visit post-treatment in the Company’s open-label Phase 1/2 First-in-Human (FIH) clinical trial at Dayton Children’s Hospital (Dayton, Ohio).

Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Entasis Therapeutics Holdings Inc.

During the recent 2022 CytoSorb Users’ Meeting in Berlin, Germany hosted by CytoSorbents Corporation (NASDAQ: CTSO), leading critical care specialists, cardiac surgeons, and research scientists from around the world highlighted the use of CytoSorb® blood purification across a broad range of applications driven by major current trends in healthcare.

Forecast to 2027,’ thoroughly examines the Insomnia Therapy industry to provide essential data & information for the targeted readers.

A recent report provides crucial insights along with application based and forecast information in the Global Atropine Market.

The global Heparin Sodium market size is estimated to be worth US$ 1948 million in 2021 and is forecast to a readjusted size of US$ 2451.7 million by 2028 with a CAGR of 3.3% during the forecast period 2022-2030.

The global Drugs for Herpes Labialis (Oral Herpes) market size is projected to reach US$ 3449.3 million by 2030, from US$ 2458 million in 2021, at a CAGR of 4.9% during 2022-2030.

The global Human Coagulation Factor VIII market size is estimated to be worth US$ 10230 million in 2021 and is forecast to a readjusted size of US$ 15770 million by 2030 with a CAGR of 6.3% during the forecast period 2022-2030.